AIGH Capital Management’s Biodesix BDSX Stock Holding History

AIGH Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11M	Buy	+758,328	New	+$9.4M	1.5%	21
2025 Q2	–	Sell	-213,630	Closed	-$2.67M	–	38
2025 Q1	$2.67M	Sell	213,630 -95,361	-31%	-$1.83M	1.11%	27
2024 Q4	$9.46M	Buy	308,991 +25,000	+9%	+$736K	2.96%	14
2024 Q3	$10.1M	Sell	283,991 -5,000	-2%	-$172K	2.85%	10
2024 Q2	$8.84M	Buy	288,991 +122,937	+74%	+$3.51M	2.75%	9
2024 Q1	$4.75M	Sell	166,054 -66,893	-29%	-$2.29M	1.43%	25
2023 Q4	$8.57M	Sell	232,947 -12,388	-5%	-$389K	3.39%	10
2023 Q3	$8.1M	Sell	245,335 -7,736	-3%	-$215K	3.83%	10
2023 Q2	$6.23M	Sell	253,071 -24,156	-9%	-$724K	2.54%	11
2023 Q1	$10.3M	Sell	277,227 -27,447	-9%	-$1.13M	3.8%	8
2022 Q4	$14M	Buy	+304,674	New	+$8.28M	4.62%	9

Other funds holding BDSX

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

AIGH Capital Management's BDSX Position: Q1 2026 in Review

AIGH Capital Management opened a new position in Biodesix (BDSX) in Q1 2026: 758,328 shares worth $11M. The stake represents 1.5% of the portfolio and ranks #21 among its holdings. This is a return to the name: AIGH Capital Management previously reported a position in BDSX as recently as Q1 2025.

AIGH Capital Management first reported a position in BDSX in Q4 2022 and has held it in 11 quarters since. The position peaked at $14M in Q4 2022. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

AIGH Capital Management held 758,328 shares of Biodesix worth $11M as of Q1 2026.
Biodesix was a new AIGH Capital Management position in Q1 2026.
Biodesix made up 1.5% of AIGH Capital Management's portfolio in Q1 2026, its #21 holding.
AIGH Capital Management first reported a position in Biodesix in Q4 2022 and has held it in 11 quarters since.
AIGH Capital Management's Biodesix position peaked at $14M in Q4 2022.
40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on AIGH Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.